<VariationArchive VariationID="265173" VariationName="NM_000161.3(GCH1):c.631_632del (p.Met211fs)" VariationType="Deletion" Accession="VCV000265173" Version="28" RecordType="classified" NumberOfSubmissions="7" NumberOfSubmitters="7" DateLastUpdated="2024-07-15" DateCreated="2016-10-10" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="260057" VariationID="265173">
      <GeneList>
        <Gene Symbol="GCH1" FullName="GTP cyclohydrolase 1" GeneID="2643" HGNC_ID="HGNC:4193" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>14q22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="54842017" stop="54902826" display_start="54842017" display_stop="54902826" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="55308722" stop="55369541" display_start="55308722" display_stop="55369541" Strand="-" />
          </Location>
          <OMIM>600225</OMIM>
          <Haploinsufficiency last_evaluated="2023-02-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GCH1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-02-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GCH1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000161.3(GCH1):c.631_632del (p.Met211fs)</Name>
      <CanonicalSPDI>NC_000014.9:54844137:AT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>14q22.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="54844138" stop="54844139" display_start="54844138" display_stop="54844139" variantLength="2" positionVCF="54844137" referenceAlleleVCF="CAT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="55310856" stop="55310857" display_start="55310856" display_stop="55310857" variantLength="2" positionVCF="55310855" referenceAlleleVCF="CAT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>M211fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.8" sequenceAccession="NC_000014" sequenceVersion="8" change="g.55310856_55310857del" Assembly="GRCh37">
            <Expression>NC_000014.8:g.55310856_55310857del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.9" sequenceAccession="NC_000014" sequenceVersion="9" change="g.54844138_54844139del" Assembly="GRCh38">
            <Expression>NC_000014.9:g.54844138_54844139del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008647.1" sequenceAccession="NG_008647" sequenceVersion="1" change="g.63686_63687del">
            <Expression>NG_008647.1:g.63686_63687del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000161.3" sequenceAccession="NM_000161" sequenceVersion="3" change="c.631_632del" MANESelect="true">
            <Expression>NM_000161.3:c.631_632del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000152.1" sequenceAccession="NP_000152" sequenceVersion="1" change="p.Met211fs">
            <Expression>NP_000152.1:p.Met211fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001024024.2" sequenceAccession="NM_001024024" sequenceVersion="2" change="c.631_632del">
            <Expression>NM_001024024.2:c.631_632del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001019195.1" sequenceAccession="NP_001019195" sequenceVersion="1" change="p.Met211fs">
            <Expression>NP_001019195.1:p.Met211fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001024071.2" sequenceAccession="NM_001024071" sequenceVersion="2" change="c.627-1085_627-1084del">
            <Expression>NM_001024071.2:c.627-1085_627-1084del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001024070.2" sequenceAccession="NM_001024070" sequenceVersion="2" change="c.627-270_627-269del">
            <Expression>NM_001024070.2:c.627-270_627-269del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000161.2" sequenceAccession="NM_000161" sequenceVersion="2" change="c.631_632del">
            <Expression>NM_000161.2:c.631_632del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA10588575" DB="ClinGen" />
        <XRef Type="rs" ID="886039379" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000161.3(GCH1):c.631_632del (p.Met211fs) AND not provided" Accession="RCV000255238" Version="14">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-11-01" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000161.3(GCH1):c.631_632del (p.Met211fs) AND Dystonia 5" Accession="RCV001197727" Version="7">
        <ClassifiedConditionList TraitSetID="2548">
          <ClassifiedCondition DB="MedGen" ID="C1851920">Dystonia 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-08-22" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000161.3(GCH1):c.631_632del (p.Met211fs) AND multiple conditions" Accession="RCV001221402" Version="7">
        <ClassifiedConditionList TraitSetID="19215">
          <ClassifiedCondition DB="MedGen" ID="C1851920">Dystonia 5</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0268467">GTP cyclohydrolase I deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-06-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000161.3(GCH1):c.631_632del (p.Met211fs) AND Inborn genetic diseases" Accession="RCV001266568" Version="5">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-03-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-22" NumberOfSubmissions="7" NumberOfSubmitters="7" DateCreated="2016-10-10" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19491146</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23430498</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25181484</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9566388</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9778264</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2548" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1573" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Dystonia 5, Dopa-responsive type</ElementValue>
                <XRef ID="Dystonia+5%2C+Dopa-Responsive+Type/2419" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DYT-GCH1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Dystonia 5</ElementValue>
                <XRef ID="MONDO:0007495" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia, progressive, with diurnal variation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia-Parkinsonism with diurnal fluctuation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Segawa syndrome, autosomal dominant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia, Dopa-responsive, autosomal dominant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia, DOPA-responsive, with or without hyperphenylalaninemia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DYT5</ElementValue>
                <XRef ID="GTR000288689" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="128230" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">DRD</ElementValue>
                <XRef Type="MIM" ID="128230" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12144" />
                <XRef ID="12144" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9817" />
                <XRef ID="9817" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">GTP cyclohydrolase 1-deficient dopa-responsive dystonia (GTPCH1-deficient DRD) is characterized by childhood-onset dystonia and a dramatic and sustained response to low doses of oral administration of levodopa. This disorder typically presents with gait disturbance caused by foot dystonia, later development of parkinsonism, and diurnal fluctuation of symptoms (aggravation of symptoms toward the evening and alleviation of symptoms in the morning after sleep). Initial symptoms are often gait difficulties attributable to flexion-inversion (equinovarus posture) of the foot. Occasionally, initial symptoms are arm dystonia, postural tremor of the hand, or slowness of movements. Brisk deep-tendon reflexes in the legs, ankle clonus, and/or the striatal toe (dystonic extension of the big toe) are present in many affected individuals. In general, gradual progression to generalized dystonia is observed. Intellectual, cerebellar, sensory, and autonomic disturbances generally do not occur.</Attribute>
                <XRef ID="NBK1508" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301681</ID>
                <ID Source="BookShelf">NBK1508</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2011">
                <ID Source="PubMed">20482602</ID>
              </Citation>
              <XRef ID="98808" DB="Orphanet" />
              <XRef ID="C1851920" DB="MedGen" />
              <XRef ID="MONDO:0007495" DB="MONDO" />
              <XRef Type="MIM" ID="128230" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="19215" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2190" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">GTP cyclohydrolase I deficiency</ElementValue>
                <XRef ID="MONDO:0100184" DB="MONDO" />
                <XRef ID="23447005" DB="SNOMED CT" />
              </Name>
              <XRef ID="C0268467" DB="MedGen" />
              <XRef ID="MONDO:0100184" DB="MONDO" />
            </Trait>
            <Trait ID="1573" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Dystonia 5, Dopa-responsive type</ElementValue>
                <XRef ID="Dystonia+5%2C+Dopa-Responsive+Type/2419" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DYT-GCH1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Dystonia 5</ElementValue>
                <XRef ID="MONDO:0007495" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia, progressive, with diurnal variation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia-Parkinsonism with diurnal fluctuation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Segawa syndrome, autosomal dominant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia, Dopa-responsive, autosomal dominant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia, DOPA-responsive, with or without hyperphenylalaninemia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DYT5</ElementValue>
                <XRef ID="GTR000288689" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="128230" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">DRD</ElementValue>
                <XRef Type="MIM" ID="128230" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12144" />
                <XRef ID="12144" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9817" />
                <XRef ID="9817" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">GTP cyclohydrolase 1-deficient dopa-responsive dystonia (GTPCH1-deficient DRD) is characterized by childhood-onset dystonia and a dramatic and sustained response to low doses of oral administration of levodopa. This disorder typically presents with gait disturbance caused by foot dystonia, later development of parkinsonism, and diurnal fluctuation of symptoms (aggravation of symptoms toward the evening and alleviation of symptoms in the morning after sleep). Initial symptoms are often gait difficulties attributable to flexion-inversion (equinovarus posture) of the foot. Occasionally, initial symptoms are arm dystonia, postural tremor of the hand, or slowness of movements. Brisk deep-tendon reflexes in the legs, ankle clonus, and/or the striatal toe (dystonic extension of the big toe) are present in many affected individuals. In general, gradual progression to generalized dystonia is observed. Intellectual, cerebellar, sensory, and autonomic disturbances generally do not occur.</Attribute>
                <XRef ID="NBK1508" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301681</ID>
                <ID Source="BookShelf">NBK1508</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2011">
                <ID Source="PubMed">20482602</ID>
              </Citation>
              <XRef ID="98808" DB="Orphanet" />
              <XRef ID="C1851920" DB="MedGen" />
              <XRef ID="MONDO:0007495" DB="MONDO" />
              <XRef Type="MIM" ID="128230" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="616364" SubmissionDate="2019-01-29" DateLastUpdated="2016-10-10" DateCreated="2016-10-10">
        <ClinVarSubmissionID localKey="GDX:23776|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000321711" DateUpdated="2016-10-10" DateCreated="2016-10-10" Type="SCV" Version="7" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-06-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.631_632delAT variant in the GCH1 gene has been reported previously in multiple individuals with dopa-responsive dystonia (Furukawa et al., 1998; Bandmann et al., 1998; Clot et al., 2009; Sun et al., 2014). The c.631_632delAT variant causes a frameshift starting with codon Methionine 211, changes this amino acid to a Valine residue, and creates a premature Stop codon at position 38 of the new reading frame, denoted p.Met211ValfsX38. This variant is predicted to cause loss of normal protein function through protein truncation. The c.631_632delAT variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret c.631_632delAT as a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GCH1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000161.2:c.631_632delAT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2857079" SubmissionDate="2020-10-23" DateLastUpdated="2020-11-28" DateCreated="2020-11-28">
        <ClinVarSubmissionID localKey="report_configuration_variant_id:7305" />
        <ClinVarAccession Accession="SCV001446691" DateUpdated="2020-11-28" DateCreated="2020-11-28" Type="SCV" Version="1" SubmitterName="Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen" OrgID="506385" OrganizationCategory="laboratory" OrgAbbreviation="IMGAG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SampleLocalID">DX196787</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001332" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001337" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="14" alternateAllele="C" referenceAllele="CAT" start="55310855" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2696587" SubmissionDate="2020-11-24" DateLastUpdated="2020-07-04" DateCreated="2020-07-04">
        <ClinVarSubmissionID localKey="NM_000161.2:c.631_632delAT|OMIM:128230" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001368506" DateUpdated="2020-07-04" DateCreated="2020-07-04" Type="SCV" Version="2" SubmitterName="Centre for Mendelian Genomics, University Medical Centre Ljubljana" OrgID="505952" OrganizationCategory="clinic" OrgAbbreviation="CMG-UMCL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-10-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PS1,PM2.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000161.2:c.631_632delAT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="128230" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8622351</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2728351" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="4918786|MedGen:C0268467;C1851920" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001393445" DateUpdated="2024-02-28" DateCreated="2020-07-16" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9778264</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19491146</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23430498</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has been observed in several individuals and families affected with dopa-responsive dystonia (PMID: 9778264, 19491146, 23430498). ClinVar contains an entry for this variant (Variation ID: 265173). This variant is not present in population databases (ExAC no frequency). This sequence change results in a premature translational stop signal in the GCH1 gene (p.Met211Valfs*38). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 40 amino acids of the GCH1 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GCH1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000014.8:g.55310856_55310857del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268467" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1851920" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB6933842</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2852835" SubmissionDate="2024-04-19" DateLastUpdated="2024-05-01" DateCreated="2020-11-21">
        <ClinVarSubmissionID localKey="a9879786|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001444744" DateUpdated="2024-05-01" DateCreated="2020-11-21" Type="SCV" Version="4" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-03-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9566388</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9778264</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19491146</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25181484</ID>
          </Citation>
          <Comment>The alteration results in a premature stop codon:_x000D_ _x000D_ The c.631_632delAT (p.M211Vfs*38) alteration, located in coding exon 6 of the GCH1 gene, results from a deletion of 2 nucleotides from position 631 to 632, causing a translational frameshift with a predicted alternate stop codon after 38 amino acids. Frameshifts are typically deleterious in nature; however, this frameshift occurs at the 3' terminus of GCH1, is not expected to trigger nonsense-mediated mRNA decay, and a truncated mutant protein could still be expressed (Maquat, 2004). This alteration impacts the last 40 amino acids of the protein and the exact functional impact of these altered amino acids is unknown at this time. The alteration is not observed in population databases:_x000D_ _x000D_ Based on data from the Genome Aggregation Database (gnomAD), the GCH1 c.631_632delAT alteration was not observed, with coverage at this position. The alteration has been observed in affected individuals:_x000D_ _x000D_ This variant has been reported previously in multiple individuals with dopa-responsive dystonia (Bandmann, 1998; Clot, 2009; Furukawa, 1998; Sun, 2014). Based on the available evidence, this alteration is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GCH1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000161.2:c.631_632delAT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>AVA4 Submission_Through01042023</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava4_1</SubmissionName>
          <SubmissionName>NovelandUpdateExomeDeposit_ExomeProgenyThrough080120</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7569632" SubmissionDate="2023-10-19" DateLastUpdated="2023-10-21" DateCreated="2023-10-21">
        <ClinVarSubmissionID localKey="104-20230924" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV004045948" DateUpdated="2023-10-21" DateCreated="2023-10-21" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München" OrgID="500240" OrganizationCategory="clinic" OrgAbbreviation="IHG-MRI-TUM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Classification criteria August 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/inodbbrd/classification_criteria.pdf</URL>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Disease">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0001332" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GCH1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="14" alternateAllele="C" referenceAllele="CAT" start="55310855" stop="55310857" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="128230" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2023-09-24</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5508668" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2023-01-21">
        <ClinVarSubmissionID localKey="126986|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002822137" DateUpdated="2024-07-15" DateCreated="2023-01-21" Type="SCV" Version="11" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>GCH1: PVS1:Strong, PM2, PP4:Moderate, PS4:Moderate</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GCH1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="14" alternateAllele="C" referenceAllele="CAT" start="55310855" stop="55310857" variantLength="3" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2696587" TraitType="Disease" MappingType="XRef" MappingValue="128230" MappingRef="OMIM">
        <MedGen CUI="C1851920" Name="Dystonia 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2857079" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001332" MappingRef="HP">
        <MedGen CUI="C0013421" Name="Dystonic disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7569632" TraitType="Disease" MappingType="XRef" MappingValue="HP:0001332" MappingRef="HP">
        <MedGen CUI="C0013421" Name="Dystonic disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2728351" TraitType="Disease" MappingType="XRef" MappingValue="C0268467" MappingRef="MedGen">
        <MedGen CUI="C0268467" Name="GTP cyclohydrolase I deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="616364" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7569632" TraitType="Disease" MappingType="XRef" MappingValue="128230" MappingRef="OMIM">
        <MedGen CUI="C1851920" Name="Dystonia 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2857079" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001337" MappingRef="HP">
        <MedGen CUI="C0040822" Name="Tremor" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2728351" TraitType="Disease" MappingType="XRef" MappingValue="C1851920" MappingRef="MedGen">
        <MedGen CUI="C1851920" Name="Dystonia 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5508668" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2857079" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2852835" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

